Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025)
Autolus Therapeutics' (AUTL) quarterly Exchange Rate Effect came in at $589000.0 in Q4 2025, up 101.54% YoY from $292247.9 in Q4 2024, and up 116.44% on a QoQ basis from -$3.6 million in Q3 2025.
Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has 8 years of Exchange Rate Effect data on file, last reported at $589000.0 in Q4 2025.
- Quarterly Exchange Rate Effect rose 101.54% year-over-year to $589000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 2505.75% YoY) and the FY2025 annual result came in at $6.3 million, up 2505.75% from the prior year.
- Exchange Rate Effect climbed to $589000.0 in Q4 2025, from -$3.6 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $37.7 million in Q3 2024 to a low of -$38.2 million in Q4 2024.
- A 5-year average of -$404100.0 and a median of $1.0 million in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1409.95% in 2022, down 1502.55% in 2022.
- Tracing AUTL's Exchange Rate Effect over 5 years: stood at $734000.0 in 2021, then surged by 1409.95% to $11.1 million in 2022, then slipped by 11.82% to $9.8 million in 2023, then sank by 491.04% to -$38.2 million in 2024, then soared by 101.54% to $589000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $589000.0 (Q4 2025), -$3.6 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 589,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | -3.58 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | -38.22 Mn |
| Dec 31, 2024 | -38.22 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | -9.30 Mn |
| Sep 30, 2023 | -9.30 Mn |